25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SUN PHARMACEUTICAL INDUSTRIES LTD.
Buy, Hold or Sell?

Let's analyze SUN PHARMACEUTICAL INDUSTRIES LTD. together

I guess you are interested in SUN PHARMACEUTICAL INDUSTRIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SUN PHARMACEUTICAL INDUSTRIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about SUN PHARMACEUTICAL INDUSTRIES LTD.

I send you an email if I find something interesting about SUN PHARMACEUTICAL INDUSTRIES LTD..

1. Quick Overview

1.1. Quick analysis of SUN PHARMACEUTICAL INDUSTRIES LTD. (30 sec.)










1.2. What can you expect buying and holding a share of SUN PHARMACEUTICAL INDUSTRIES LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.57
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR279.69
Expected worth in 1 year
INR464.91
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR233.54
Return On Investment
12.6%

For what price can you sell your share?

Current Price per Share
INR1,852.20
Expected price per share
INR1,604 - INR
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of SUN PHARMACEUTICAL INDUSTRIES LTD. (5 min.)




Live pricePrice per Share (EOD)
INR1,852.20
Intrinsic Value Per Share
INR232.30 - INR649.78
Total Value Per Share
INR511.99 - INR929.47

2.2. Growth of SUN PHARMACEUTICAL INDUSTRIES LTD. (5 min.)




Is SUN PHARMACEUTICAL INDUSTRIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$7.9b$6.6b$1.3b16.6%

How much money is SUN PHARMACEUTICAL INDUSTRIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$1.1b$1b$131.2m11.5%
Net Profit Margin20.1%19.3%--

How much money comes from the company's main activities?

2.3. Financial Health of SUN PHARMACEUTICAL INDUSTRIES LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of SUN PHARMACEUTICAL INDUSTRIES LTD.?

Welcome investor! SUN PHARMACEUTICAL INDUSTRIES LTD.'s management wants to use your money to grow the business. In return you get a share of SUN PHARMACEUTICAL INDUSTRIES LTD..

First you should know what it really means to hold a share of SUN PHARMACEUTICAL INDUSTRIES LTD.. And how you can make/lose money.

Speculation

The Price per Share of SUN PHARMACEUTICAL INDUSTRIES LTD. is INR1,852. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of SUN PHARMACEUTICAL INDUSTRIES LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in SUN PHARMACEUTICAL INDUSTRIES LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR279.69. Based on the TTM, the Book Value Change Per Share is INR46.31 per quarter. Based on the YOY, the Book Value Change Per Share is INR33.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR12.08 per quarter.
Based on historical numbers we can estimate the returns while holding a share of SUN PHARMACEUTICAL INDUSTRIES LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.470.0%0.470.0%0.420.0%0.280.0%0.240.0%
Usd Book Value Change Per Share0.550.0%0.550.0%0.400.0%0.250.0%0.230.0%
Usd Dividend Per Share0.140.0%0.140.0%0.120.0%0.100.0%0.060.0%
Usd Total Gains Per Share0.690.0%0.690.0%0.520.0%0.360.0%0.300.0%
Usd Price Per Share19.28-19.28-11.70-10.63-9.49-
Price to Earnings Ratio40.60-40.60-27.84-41.47-42.82-
Price-to-Total Gains Ratio27.75-27.75-22.46-35.51-36.72-
Price to Book Ratio5.79-5.79-4.21-3.91-4.45-
Price-to-Total Gains Ratio27.75-27.75-22.46-35.51-36.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share22.04118
Number of shares45
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.140.10
Usd Book Value Change Per Share0.550.25
Usd Total Gains Per Share0.690.36
Gains per Quarter (45 shares)31.2716.16
Gains per Year (45 shares)125.0664.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12699115194655
2521982403892120
37829836556138185
410339749075184250
512949661594229315
6155595740113275380
7181694865131321445
8207794990150367510
92338931115169413575
102599921240188459640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%11.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of SUN PHARMACEUTICAL INDUSTRIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--46.30746.3070%33.277+39%21.420+116%19.447+138%
Book Value Per Share--279.686279.6860%233.379+20%219.094+28%183.665+52%
Current Ratio--2.5602.5600%2.002+28%2.100+22%1.979+29%
Debt To Asset Ratio--0.2150.2150%0.307-30%0.297-28%0.348-38%
Debt To Equity Ratio--0.2880.2880%0.442-35%0.430-33%0.555-48%
Dividend Per Share--12.07912.0790%10.498+15%8.765+38%5.446+122%
Eps--39.91339.9130%35.316+13%23.333+71%20.340+96%
Free Cash Flow Per Share--41.40041.4000%11.977+246%25.265+64%17.162+141%
Free Cash Flow To Equity Per Share--41.40041.4000%21.880+89%13.167+214%7.099+483%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--649.781--------
Intrinsic Value_10Y_min--232.301--------
Intrinsic Value_1Y_max--36.237--------
Intrinsic Value_1Y_min--18.896--------
Intrinsic Value_3Y_max--130.885--------
Intrinsic Value_3Y_min--60.906--------
Intrinsic Value_5Y_max--252.064--------
Intrinsic Value_5Y_min--107.123--------
Market Cap4444039114905.601+13%3888122318885.0003888122318885.0000%2358786209007.000+65%2144141702590.800+81%1912808332651.690+103%
Net Profit Margin--0.2010.2010%0.193+4%0.136+48%0.140+44%
Operating Margin----0%0.211-100%0.153-100%0.187-100%
Operating Ratio--1.0341.0340%1.048-1%1.086-5%1.079-4%
Pb Ratio6.622+13%5.7945.7940%4.212+38%3.906+48%4.448+30%
Pe Ratio46.406+13%40.60140.6010%27.837+46%41.466-2%42.816-5%
Price Per Share1852.200+13%1620.5001620.5000%983.100+65%893.640+81%797.225+103%
Price To Free Cash Flow Ratio44.739+13%39.14339.1430%82.080-52%39.2130%32.768+19%
Price To Total Gains Ratio31.723+13%27.75527.7550%22.458+24%35.511-22%36.717-24%
Quick Ratio--1.2541.2540%1.807-31%1.574-20%1.427-12%
Return On Assets--0.1120.1120%0.105+7%0.072+55%0.072+55%
Return On Equity--0.1500.1500%0.151-1%0.103+46%0.114+32%
Total Gains Per Share--58.38658.3860%43.775+33%30.185+93%24.893+135%
Usd Book Value--7985610430.0007985610430.0000%6663450220.000+20%6255587240.000+28%5244025360.000+52%
Usd Book Value Change Per Share--0.5510.5510%0.396+39%0.255+116%0.231+138%
Usd Book Value Per Share--3.3283.3280%2.777+20%2.607+28%2.186+52%
Usd Dividend Per Share--0.1440.1440%0.125+15%0.104+38%0.065+122%
Usd Eps--0.4750.4750%0.420+13%0.278+71%0.242+96%
Usd Free Cash Flow--1182047230.0001182047230.0000%341976250.000+246%721364434.000+64%490007133.000+141%
Usd Free Cash Flow Per Share--0.4930.4930%0.143+246%0.301+64%0.204+141%
Usd Free Cash Flow To Equity Per Share--0.4930.4930%0.260+89%0.157+214%0.084+483%
Usd Market Cap52884065467.377+13%46268655594.73246268655594.7320%28069555887.183+65%25515286260.831+81%22762419158.555+103%
Usd Price Per Share22.041+13%19.28419.2840%11.699+65%10.634+81%9.487+103%
Usd Profit--1139589220.0001139589220.0000%1008356020.000+13%666196272.000+71%580744038.000+96%
Usd Revenue--5683255550.0005683255550.0000%5222395920.000+9%4679895388.000+21%4041800609.000+41%
Usd Total Gains Per Share--0.6950.6950%0.521+33%0.359+93%0.296+135%
 EOD+4 -4MRQTTM+0 -0YOY+29 -65Y+30 -510Y+29 -6

3.3 Fundamental Score

Let's check the fundamental score of SUN PHARMACEUTICAL INDUSTRIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1546.406
Price to Book Ratio (EOD)Between0-16.622
Net Profit Margin (MRQ)Greater than00.201
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.254
Current Ratio (MRQ)Greater than12.560
Debt to Asset Ratio (MRQ)Less than10.215
Debt to Equity Ratio (MRQ)Less than10.288
Return on Equity (MRQ)Greater than0.150.150
Return on Assets (MRQ)Greater than0.050.112
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of SUN PHARMACEUTICAL INDUSTRIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.235
Ma 20Greater thanMa 501,806.655
Ma 50Greater thanMa 1001,717.164
Ma 100Greater thanMa 2001,610.545
OpenGreater thanClose1,864.900
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About SUN PHARMACEUTICAL INDUSTRIES LTD.

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-09-14 22:16:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit SUN PHARMACEUTICAL INDUSTRIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 20.1% means that ₹0.20 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 20.1%. The company is making a huge profit. +2
  • The TTM is 20.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.1%TTM20.1%0.0%
TTM20.1%YOY19.3%+0.7%
TTM20.1%5Y13.6%+6.5%
5Y13.6%10Y14.0%-0.4%
4.3.1.2. Return on Assets

Shows how efficient SUN PHARMACEUTICAL INDUSTRIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 11.2% Return on Assets means that SUN PHARMACEUTICAL INDUSTRIES LTD. generated ₹0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 11.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 11.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ11.2%TTM11.2%0.0%
TTM11.2%YOY10.5%+0.7%
TTM11.2%5Y7.2%+4.0%
5Y7.2%10Y7.2%0.0%
4.3.1.3. Return on Equity

Shows how efficient SUN PHARMACEUTICAL INDUSTRIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 15.0% Return on Equity means SUN PHARMACEUTICAL INDUSTRIES LTD. generated ₹0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 15.0%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 15.0%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.0%TTM15.0%0.0%
TTM15.0%YOY15.1%-0.1%
TTM15.0%5Y10.3%+4.7%
5Y10.3%10Y11.4%-1.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of SUN PHARMACEUTICAL INDUSTRIES LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient SUN PHARMACEUTICAL INDUSTRIES LTD. is operating .

  • Measures how much profit SUN PHARMACEUTICAL INDUSTRIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY21.1%-21.1%
TTM-5Y15.3%-15.3%
5Y15.3%10Y18.7%-3.4%
4.3.2.2. Operating Ratio

Measures how efficient SUN PHARMACEUTICAL INDUSTRIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.03 means that the operating costs are ₹1.03 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 1.034. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.034. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.034TTM1.0340.000
TTM1.034YOY1.048-0.014
TTM1.0345Y1.086-0.053
5Y1.08610Y1.079+0.007
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of SUN PHARMACEUTICAL INDUSTRIES LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if SUN PHARMACEUTICAL INDUSTRIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.56 means the company has ₹2.56 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 2.560. The company is able to pay all its short-term debts. +1
  • The TTM is 2.560. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.560TTM2.5600.000
TTM2.560YOY2.002+0.557
TTM2.5605Y2.100+0.460
5Y2.10010Y1.979+0.120
4.4.3.2. Quick Ratio

Measures if SUN PHARMACEUTICAL INDUSTRIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.25 means the company can pay off ₹1.25 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 1.254. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.254. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.254TTM1.2540.000
TTM1.254YOY1.807-0.554
TTM1.2545Y1.574-0.320
5Y1.57410Y1.427+0.147
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of SUN PHARMACEUTICAL INDUSTRIES LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of SUN PHARMACEUTICAL INDUSTRIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that SUN PHARMACEUTICAL INDUSTRIES LTD. assets are financed with 21.5% credit (debt) and the remaining percentage (100% - 21.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 0.215. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.215. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.215TTM0.2150.000
TTM0.215YOY0.307-0.092
TTM0.2155Y0.297-0.082
5Y0.29710Y0.348-0.051
4.5.4.2. Debt to Equity Ratio

Measures if SUN PHARMACEUTICAL INDUSTRIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 28.8% means that company has ₹0.29 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The MRQ is 0.288. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.288. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.288TTM0.2880.000
TTM0.288YOY0.442-0.154
TTM0.2885Y0.430-0.141
5Y0.43010Y0.555-0.125
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings SUN PHARMACEUTICAL INDUSTRIES LTD. generates.

  • Above 15 is considered overpriced but always compare SUN PHARMACEUTICAL INDUSTRIES LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 40.60 means the investor is paying ₹40.60 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The EOD is 46.406. Based on the earnings, the company is overpriced. -1
  • The MRQ is 40.601. Based on the earnings, the company is overpriced. -1
  • The TTM is 40.601. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD46.406MRQ40.601+5.805
MRQ40.601TTM40.6010.000
TTM40.601YOY27.837+12.764
TTM40.6015Y41.466-0.864
5Y41.46610Y42.816-1.351
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The EOD is 44.739. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 39.143. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 39.143. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD44.739MRQ39.143+5.597
MRQ39.143TTM39.1430.000
TTM39.143YOY82.080-42.938
TTM39.1435Y39.213-0.070
5Y39.21310Y32.768+6.445
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of SUN PHARMACEUTICAL INDUSTRIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 5.79 means the investor is paying ₹5.79 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of SUN PHARMACEUTICAL INDUSTRIES LTD.:

  • The EOD is 6.622. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.794. Based on the equity, the company is overpriced. -1
  • The TTM is 5.794. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.622MRQ5.794+0.828
MRQ5.794TTM5.7940.000
TTM5.794YOY4.212+1.582
TTM5.7945Y3.906+1.888
5Y3.90610Y4.448-0.542
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets854,628,800
Total Liabilities183,569,100
Total Stockholder Equity636,667,500
 As reported
Total Liabilities 183,569,100
Total Stockholder Equity+ 636,667,500
Total Assets = 854,628,800

Assets

Total Assets854,628,800
Total Current Assets434,749,800
Long-term Assets419,879,000
Total Current Assets
Cash And Cash Equivalents 92,856,500
Short-term Investments 100,430,000
Net Receivables 112,493,700
Inventory 98,682,900
Other Current Assets 646,700
Total Current Assets  (as reported)434,749,800
Total Current Assets  (calculated)405,109,800
+/- 29,640,000
Long-term Assets
Property Plant Equipment 113,000,500
Goodwill 85,989,500
Intangible Assets 86,662,600
Long-term Assets Other 4,739,300
Long-term Assets  (as reported)419,879,000
Long-term Assets  (calculated)290,391,900
+/- 129,487,100

Liabilities & Shareholders' Equity

Total Current Liabilities169,844,000
Long-term Liabilities13,725,100
Total Stockholder Equity636,667,500
Total Current Liabilities
Short Long Term Debt 28,443,600
Accounts payable 56,533,000
Other Current Liabilities 9,579,200
Total Current Liabilities  (as reported)169,844,000
Total Current Liabilities  (calculated)94,555,800
+/- 75,288,200
Long-term Liabilities
Long term Debt 13,300
Capital Lease Obligations Min Short Term Debt4,279,800
Long-term Liabilities Other 112,000
Long-term Liabilities  (as reported)13,725,100
Long-term Liabilities  (calculated)4,405,100
+/- 9,320,000
Total Stockholder Equity
Retained Earnings 501,545,500
Total Stockholder Equity (as reported)636,667,500
Total Stockholder Equity (calculated)501,545,500
+/- 135,122,000
Other
Capital Stock2,399,300
Common Stock Shares Outstanding 2,399,335
Net Invested Capital 665,124,400
Net Working Capital 264,905,800
Property Plant and Equipment Gross 238,760,900



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
293,708,200
487,985,000
555,302,700
614,102,400
645,163,500
646,938,100
682,524,600
676,667,300
698,077,700
807,435,900
854,628,800
854,628,800807,435,900698,077,700676,667,300682,524,600646,938,100645,163,500614,102,400555,302,700487,985,000293,708,200
   > Total Current Assets 
186,864,600
289,157,500
299,413,000
329,536,500
316,359,000
310,691,900
316,541,600
304,420,800
350,149,800
398,619,400
434,749,800
434,749,800398,619,400350,149,800304,420,800316,541,600310,691,900316,359,000329,536,500299,413,000289,157,500186,864,600
       Cash And Cash Equivalents 
75,901,500
109,980,400
53,892,600
51,051,900
55,154,400
34,314,100
19,103,300
30,003,500
26,769,400
43,702,300
92,856,500
92,856,50043,702,30026,769,40030,003,50019,103,30034,314,10055,154,40051,051,90053,892,600109,980,40075,901,500
       Short-term Investments 
19,984,600
21,174,300
7,469,400
3,268,600
60,516,500
41,165,800
52,631,900
31,301,600
76,960,800
93,903,400
100,430,000
100,430,00093,903,40076,960,80031,301,60052,631,90041,165,80060,516,5003,268,6007,469,40021,174,30019,984,600
       Net Receivables 
28,122,900
63,250,900
67,605,100
84,976,200
84,163,500
100,629,900
94,212,400
90,614,000
105,928,900
114,385,100
112,493,700
112,493,700114,385,100105,928,90090,614,00094,212,400100,629,90084,163,50084,976,20067,605,10063,250,90028,122,900
       Inventory 
31,230,100
56,679,900
64,225,400
77,351,200
68,806,900
78,859,800
82,692,200
93,618,000
93,108,400
105,130,500
98,682,900
98,682,900105,130,50093,108,40093,618,00082,692,20078,859,80068,806,90077,351,20064,225,40056,679,90031,230,100
       Other Current Assets 
30,117,400
35,344,700
8,891,900
10,137,000
20,813,900
16,623,600
17,488,100
13,478,800
15,804,900
4,143,500
646,700
646,7004,143,50015,804,90013,478,80017,488,10016,623,60020,813,90010,137,0008,891,90035,344,70030,117,400
   > Long-term Assets 
0
0
0
284,565,900
326,669,000
336,246,200
365,983,000
372,246,500
347,848,900
408,602,500
419,879,000
419,879,000408,602,500347,848,900372,246,500365,983,000336,246,200326,669,000284,565,900000
       Property Plant Equipment 
43,397,200
85,069,500
87,866,000
100,600,500
105,935,000
109,382,100
112,263,400
111,715,100
111,688,900
113,537,300
113,000,500
113,000,500113,537,300111,688,900111,715,100112,263,400109,382,100105,935,000100,600,50087,866,00085,069,50043,397,200
       Goodwill 
29,123,200
50,611,600
56,347,400
55,362,200
56,067,100
59,557,700
64,814,600
62,876,400
65,912,800
87,127,100
85,989,500
85,989,50087,127,10065,912,80062,876,40064,814,60059,557,70056,067,10055,362,20056,347,40050,611,60029,123,200
       Long Term Investments 
7,875,600
5,988,700
19,137,600
14,905,400
0
0
0
0
0
0
0
000000014,905,40019,137,6005,988,7007,875,600
       Intangible Assets 
4,067,800
11,529,700
36,263,600
48,802,800
51,176,000
63,537,100
63,594,500
56,606,600
61,917,900
93,268,400
86,662,600
86,662,60093,268,40061,917,90056,606,60063,594,50063,537,10051,176,00048,802,80036,263,60011,529,7004,067,800
       Long-term Assets Other 
0
0
0
17,700
16,700
1,700
1,700
5,367,400
-2,649,400
3,723,700
4,739,300
4,739,3003,723,700-2,649,4005,367,4001,7001,70016,70017,700000
> Total Liabilities 
89,246,900
203,092,200
225,477,900
247,705,700
262,022,400
232,847,500
229,880,100
212,039,500
217,965,500
247,482,100
183,569,100
183,569,100247,482,100217,965,500212,039,500229,880,100232,847,500262,022,400247,705,700225,477,900203,092,20089,246,900
   > Total Current Liabilities 
59,895,900
161,468,100
131,439,600
178,870,200
198,643,200
173,396,200
157,064,300
161,456,300
172,005,500
199,063,800
169,844,000
169,844,000199,063,800172,005,500161,456,300157,064,300173,396,200198,643,200178,870,200131,439,600161,468,10059,895,900
       Short-term Debt 
25,637,200
90,073,100
52,061,200
66,549,200
79,797,000
83,707,600
55,493,800
24,449,000
4,685,200
59,582,600
0
059,582,6004,685,20024,449,00055,493,80083,707,60079,797,00066,549,20052,061,20090,073,10025,637,200
       Short Long Term Debt 
25,637,200
90,073,100
84,967,600
98,317,700
85,903,300
89,568,500
61,932,400
28,687,800
7,007,700
61,978,800
28,443,600
28,443,60061,978,8007,007,70028,687,80061,932,40089,568,50085,903,30098,317,70084,967,60090,073,10025,637,200
       Accounts payable 
13,282,600
32,865,400
35,829,200
43,953,900
47,662,000
41,478,700
35,836,400
39,736,600
44,793,400
56,815,200
56,533,000
56,533,00056,815,20044,793,40039,736,60035,836,40041,478,70047,662,00043,953,90035,829,20032,865,40013,282,600
       Other Current Liabilities 
20,341,800
50,176,300
39,675,100
48,355,000
61,757,100
37,338,600
48,131,800
80,043,300
104,293,500
6,427,200
9,579,200
9,579,2006,427,200104,293,50080,043,30048,131,80037,338,60061,757,10048,355,00039,675,10050,176,30020,341,800
   > Long-term Liabilities 
0
0
0
30,926,900
24,537,600
26,315,900
34,213,400
20,412,700
15,332,100
15,217,400
13,725,100
13,725,10015,217,40015,332,10020,412,70034,213,40026,315,90024,537,60030,926,900000
       Long term Debt Total 
0
0
31,103,000
14,360,800
17,720,900
15,226,100
20,289,200
8,981,300
4,817,100
5,599,100
0
05,599,1004,817,1008,981,30020,289,20015,226,10017,720,90014,360,80031,103,00000
       Capital Lease Obligations 
0
0
0
702,000
1,261,900
1,346,400
3,440,300
3,450,900
3,596,100
1,318,700
4,279,800
4,279,8001,318,7003,596,1003,450,9003,440,3001,346,4001,261,900702,000000
       Long-term Liabilities Other 
0
0
0
147,200
145,300
124,800
216,000
333,800
157,000
5,828,200
112,000
112,0005,828,200157,000333,800216,000124,800145,300147,200000
       Deferred Long Term Liability 
1,100
0
0
0
0
0
0
0
0
0
0
00000000001,100
> Total Stockholder Equity
185,249,500
256,380,900
329,824,800
366,396,700
383,141,100
414,090,600
452,644,500
464,627,800
480,112,200
559,953,800
636,667,500
636,667,500559,953,800480,112,200464,627,800452,644,500414,090,600383,141,100366,396,700329,824,800256,380,900185,249,500
   Common Stock
2,071,200
2,071,200
2,406,600
2,399,300
2,399,300
2,399,300
2,399,300
2,399,300
2,399,300
2,399,300
0
02,399,3002,399,3002,399,3002,399,3002,399,3002,399,3002,399,3002,406,6002,071,2002,071,200
   Retained Earnings 
148,801,600
204,543,600
288,800,800
342,036,000
355,358,600
369,130,400
389,052,000
401,887,400
412,363,000
475,742,000
501,545,500
501,545,500475,742,000412,363,000401,887,400389,052,000369,130,400355,358,600342,036,000288,800,800204,543,600148,801,600
   Capital Surplus 
0
0
18,591,900
11,894,600
11,929,100
11,932,900
11,874,100
11,874,100
11,874,100
11,874,100
0
011,874,10011,874,10011,874,10011,874,10011,932,90011,929,10011,894,60018,591,90000
   Treasury Stock00000000000
   Other Stockholders Equity 
20,158,700
31,545,800
15,943,100
10,066,800
13,454,100
30,628,000
49,319,100
48,467,000
53,475,800
67,788,800
0
067,788,80053,475,80048,467,00049,319,10030,628,00013,454,10010,066,80015,943,10031,545,80020,158,700



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue477,584,500
Cost of Revenue-120,696,600
Gross Profit356,887,900356,887,900
 
Operating Income (+$)
Gross Profit356,887,900
Operating Expense-372,902,700
Operating Income104,681,800-16,014,800
 
Operating Expense (+$)
Research Development0
Selling General Administrative92,174,000
Selling And Marketing Expenses0
Operating Expense372,902,70092,174,000
 
Net Interest Income (+$)
Interest Income10,229,100
Interest Expense-2,384,700
Other Finance Cost-0
Net Interest Income7,844,400
 
Pretax Income (+$)
Operating Income104,681,800
Net Interest Income7,844,400
Other Non-Operating Income Expenses0
Income Before Tax (EBT)110,878,900104,681,800
EBIT - interestExpense = -2,384,700
95,763,800
98,148,500
Interest Expense2,384,700
Earnings Before Interest and Taxes (EBIT)0113,263,600
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax110,878,900
Tax Provision-14,394,500
Net Income From Continuing Ops96,100,30096,484,400
Net Income95,763,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-7,844,400
 

Technical Analysis of SUN PHARMACEUTICAL INDUSTRIES LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of SUN PHARMACEUTICAL INDUSTRIES LTD.. The general trend of SUN PHARMACEUTICAL INDUSTRIES LTD. is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine SUN PHARMACEUTICAL INDUSTRIES LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of SUN PHARMACEUTICAL INDUSTRIES LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 1,759 > 1,609 > 1,604.

Tweet this
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current macd is 38.75.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the SUN PHARMACEUTICAL INDUSTRIES LTD. price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for SUN PHARMACEUTICAL INDUSTRIES LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the SUN PHARMACEUTICAL INDUSTRIES LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Moving Average Convergence/Divergence (MACD) ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current adx is 63.02.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy SUN PHARMACEUTICAL INDUSTRIES LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current sar is 1,832.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current rsi is 70.23. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Relative Strength Index (RSI) ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the SUN PHARMACEUTICAL INDUSTRIES LTD. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Stochastic Oscillator ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current cci is 116.91.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Commodity Channel Index (CCI) ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current cmo is 38.14.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Chande Momentum Oscillator (CMO) ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current willr is -18.24390244.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Williams %R ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of SUN PHARMACEUTICAL INDUSTRIES LTD..

SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current atr is 26.95.

SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Average True Range (ATR) ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current obv is 5,429,084.

SUN PHARMACEUTICAL INDUSTRIES LTD. Daily On-Balance Volume (OBV) ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of SUN PHARMACEUTICAL INDUSTRIES LTD.. The current mfi is 45.05.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Money Flow Index (MFI) ChartSUN PHARMACEUTICAL INDUSTRIES LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for SUN PHARMACEUTICAL INDUSTRIES LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-06-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

SUN PHARMACEUTICAL INDUSTRIES LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of SUN PHARMACEUTICAL INDUSTRIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.235
Ma 20Greater thanMa 501,806.655
Ma 50Greater thanMa 1001,717.164
Ma 100Greater thanMa 2001,610.545
OpenGreater thanClose1,864.900
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of SUN PHARMACEUTICAL INDUSTRIES LTD. with someone you think should read this too:
  • Are you bullish or bearish on SUN PHARMACEUTICAL INDUSTRIES LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about SUN PHARMACEUTICAL INDUSTRIES LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about SUN PHARMACEUTICAL INDUSTRIES LTD.

I send you an email if I find something interesting about SUN PHARMACEUTICAL INDUSTRIES LTD..


Comments

How you think about this?

Leave a comment

Stay informed about SUN PHARMACEUTICAL INDUSTRIES LTD..

Receive notifications about SUN PHARMACEUTICAL INDUSTRIES LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.